• Latest Posts

CatalYm shows importance of GDF-15 in tumor immunotherapy resistance

Exeliom Biosciences closes €24M financing for lead candidate 

In Depth 27 Jun 2023

The promise of immunotherapy for autoimmune diseases

ADVERTISEMENT
In Depth 3 May 2023

Immunotherapy in the fight against solid tumors

RNA-based nanodrugs cause cancer cells to collapse – 80% survival rate for ovarian cancer in lab models

Researchers explain how some lung tumors avoid immunotherapy

Vaccitech announces positive topline data for chronic hepatitis study

10 immunotherapy companies making waves in 2023

ADVERTISEMENT